Gonzalez-Hernandez, Dina R.
Hanouneh, Mohamad
Cervantes, C. Elena
Article History
Received: 14 May 2025
Accepted: 2 June 2025
First Online: 1 July 2025
Declarations
:
: Not applicable.
: Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.
: Mohamad Hanouneh reports serving on a speaker’s bureau for AstraZeneca, Bayer, Alexion, Novartis, and Boehringer Ingelheim. The remaining authors have nothing to disclose.
: The authors declare no competing interests.